Learning Objectives
- Review emerging strategies for immunotherapy and targeted therapy in non-small cell lung cancer, both early-stage and metastatic disease.
- Describe the emergence of novel issues in lung cancer, including equity of care, management of difficult symptoms, and neuroendocrine tumours.
- Summarize standard of care variations and recent advances in radiotherapy and systemic therapy in small cell lung cancer.”
Co-Chairs
Dr. Paul Wheatley-Price
Dr. Penelope Bradbury
